Insider Trading June 26, 2026 04:15 PM

KMX Director Sona Chawla Acquires Additional Shares Amid Shifting Analyst Sentiment

CarMax leadership transaction coincides with mixed analyst outlooks following strong Q1 fiscal 2027 results.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
KMX

On June 25, 2026, CARMAX INC (NASDAQ:KMX) director Sona Chawla executed a purchase of 2,000 common shares at $53.39 per share, bringing her direct ownership to 21,702 shares. This transaction occurs as CarMax trades at $52.70, reflecting a 35% six-month gain. Concurrently, the company reported first-quarter fiscal 2027 earnings that exceeded expectations by approximately 30%, driven by a 3% increase in vehicle volumes, including an 8% rise in the wholesale channel. Analyst responses vary, with UBS raising its price target to $57 and Mizuho adjusting its target to $43, while Barclays maintains an Underweight rating with a $31 target. CarMax trades at a P/E ratio of 33.86 times earnings, with some analysis suggesting it is slightly overvalued relative to fair value.

KMX Director Sona Chawla Acquires Additional Shares Amid Shifting Analyst Sentiment
KMX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Sona Chawla purchased 2,000 shares at $53.39 per share on June 25, 2026, increasing her direct ownership to 21,702 shares.
  • CarMax reported first-quarter fiscal 2027 earnings that exceeded expectations by approximately 30%, with vehicle volumes increasing by about 3% due to an 8% rise in the wholesale channel.
  • Analyst sentiment is divided, with UBS raising its price target to $57 and Mizuho to $43, while Barclays maintains an Underweight rating with a $31 target.

On June 25, 2026, Sona Chawla, a director at CARMAX INC (NASDAQ:KMX), executed a purchase of 2,000 shares of the company's common stock. The transaction was completed at a price of $53.39 per share, resulting in a total investment of $106,780. Following this acquisition, Ms. Chawla's direct ownership in CARMAX INC common stock stands at 21,702 shares.

This insider activity unfolds against a backdrop of recent price appreciation for CarMax shares. The stock is currently trading at $52.70, which represents a 35% gain over the preceding six-month period. According to InvestingPro analysis, the company is slightly overvalued relative to its Fair Value. This assessment is detailed alongside 14 additional ProTips and comprehensive metrics in the platform's exclusive Pro Research Report, which is available for KMX and over 1,400 US equities. The $7.4 billion company trades at a P/E ratio of 33.86 times earnings.

CarMax's recent financial disclosures provide context for the current market activity. The company reported first-quarter fiscal 2027 results that exceeded earnings per share expectations by approximately 30%. This positive performance was reflected in the company's sales and earnings, which surpassed analyst projections. Vehicle volumes increased by about 3%, largely due to an 8% rise in the wholesale channel.

Analyst responses to these developments have been mixed. UBS raised its price target for CarMax from $42 to $57, citing an expected increase in vehicle units for fiscal years 2027 and 2028. Mizuho also adjusted its price target for CarMax, increasing it to $43, while maintaining a Neutral rating. Mizuho noted changes in the company's pricing strategy under new CEO Keith Barr.

Conversely, Barclays maintained an Underweight rating on CarMax with a price target of $31, expressing concerns about the company's historical performance consistency. UBS, on another occasion, reiterated a Neutral rating with a price target of $42, despite the earnings beat. Benchmark echoed this sentiment by maintaining a Hold rating after the strong earnings performance, indicating cautious optimism about the company's future trajectory. These recent developments highlight a mix of cautious and optimistic outlooks from analysts regarding CarMax's performance and strategic changes.

Risks

  • CarMax trades at a P/E ratio of 33.86 times earnings, with analysis suggesting it is slightly overvalued relative to fair value, indicating potential valuation risks.
  • Barclays maintains an Underweight rating with a $31 price target, expressing concerns about the company's historical performance consistency.
  • Benchmark maintains a Hold rating despite strong earnings, indicating cautious optimism and potential uncertainty about future performance.

More from Insider Trading

SoftVest LP Accumulates Additional Stake in Cross Timbers Royalty Trust Jun 26, 2026 Happen Inc. Executive Transaction Analysis: CEO Sanborn's Rule 10b5-1 Sale Jun 26, 2026 PTC Therapeutics Executive Divests $2.25M in Stock via Pre-Arranged Plan Jun 26, 2026 BillionToOne CPO Executes Pre-Arranged Share Sale Amid Stock Appreciation Jun 26, 2026 CECO CFO Johansson Divests Shares Amid Merger-Driven Valuation Shift Jun 26, 2026